Hugh Gannon

1.3k total citations
14 papers, 474 citations indexed

About

Hugh Gannon is a scholar working on Molecular Biology, Oncology and Biotechnology. According to data from OpenAlex, Hugh Gannon has authored 14 papers receiving a total of 474 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 9 papers in Oncology and 3 papers in Biotechnology. Recurrent topics in Hugh Gannon's work include CRISPR and Genetic Engineering (6 papers), DNA Repair Mechanisms (6 papers) and Cancer-related Molecular Pathways (5 papers). Hugh Gannon is often cited by papers focused on CRISPR and Genetic Engineering (6 papers), DNA Repair Mechanisms (6 papers) and Cancer-related Molecular Pathways (5 papers). Hugh Gannon collaborates with scholars based in United States, Switzerland and Israel. Hugh Gannon's co-authors include Stephen N. Jones, Bruce A. Woda, Lawrence A. Donehower, Stephen Lyle, Francisca Vázquez, William C. Hahn, Matthew Meyerson, Aviad Tsherniak, Andrew H. Coles and Galen F. Gao and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nature Communications and SHILAP Revista de lepidopterología.

In The Last Decade

Hugh Gannon

14 papers receiving 469 citations

Peers

Hugh Gannon

ONCOL

IMMUN

D Soto United States

Nicola Catone Germany

Arunasalam Navaraj United States

Yoshio Okada Japan

Małgorzata Krześniak Poland

Lisanne M. Spilgies Switzerland

Maren Mundt Germany

Lillian Ramos United States

Jennifer K. Taylor United States

Agnieszka Chęcińska Netherlands

D Soto United States

Hugh Gannon

194 ×0.5

164 ×1.0

ONCOL

80 ×0.9

74 ×0.9

IMMUN

23 ×0.8

Citations per year, relative to Hugh Gannon Hugh Gannon (= 1×) peers D Soto

Countries citing papers authored by Hugh Gannon

Since Specialization

Citations

This map shows the geographic impact of Hugh Gannon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hugh Gannon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hugh Gannon more than expected).

Fields of papers citing papers by Hugh Gannon

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hugh Gannon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hugh Gannon. The network helps show where Hugh Gannon may publish in the future.

Co-authorship network of co-authors of Hugh Gannon

This figure shows the co-authorship network connecting the top 25 collaborators of Hugh Gannon. A scholar is included among the top collaborators of Hugh Gannon based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hugh Gannon. Hugh Gannon is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

14 of 14 papers shown

Tobin, Erica R., Pamela Sullivan, Hugh Gannon, et al.. (2023). Abstract 1581: KSQ-4279, a first-in-class USP1 inhibitor shows strong combination activity with multiple PARP inhibitors in BRCA mutant cancers. Cancer Research. 83(7_Supplement). 1581–1581. 2 indexed citations

Sullivan, Pamela, Yuji Mishina, Anne E. Dodson, et al.. (2023). Abstract 2771: KSQ-4279 mediated USP1 inhibition induces replication associated DNA gaps that contribute to cell death. Cancer Research. 83(7_Supplement). 2771–2771. 1 indexed citations

Lin, Sharon, Leila J. Williams, Hugh Gannon, et al.. (2022). 255 ExPRESS^TM: An accelerated process for the manufacture of KSQ-001, a CRISPR/Cas9-edited eTIL^TM product. Regular and Young Investigator Award Abstracts. A270–A270. 1 indexed citations

Shenker, Sol, Hugh Gannon, Paula Grasberger, et al.. (2021). Abstract 1337: Functional genomic characterization of the USP1 inhibitor KSQ-4279 reveals a distinct mechanism of action and resistance profile relative to other DDR targeting drugs. Cancer Research. 81(13_Supplement). 1337–1337. 7 indexed citations

Wong, Karrie, Sharon Lin, Leila J. Williams, et al.. (2021). 186 Development of KSQ-001, an engineered TIL (eTIL) therapy for solid tumors through CRISPR/Cas9-mediated editing of SOCS1. SHILAP Revista de lepidopterología. A198–A198. 1 indexed citations

Gannon, Hugh, Tao Zou, Michael K. Kießling, et al.. (2018). Identification of ADAR1 adenosine deaminase dependency in a subset of cancer cells. Nature Communications. 9(1). 5450–5450. 159 indexed citations

Roderick, Justine E., et al.. (2016). Mdm2 Phosphorylation Regulates Its Stability and Has Contrasting Effects on Oncogene and Radiation-Induced Tumorigenesis. Cell Reports. 16(10). 2618–2629. 24 indexed citations

Gannon, Hugh, Nathan O. Kaplan, Aviad Tsherniak, et al.. (2015). Identification of an “Exceptional Responder” Cell Line to MEK1 Inhibition: Clinical Implications for MEK-Targeted Therapy. Molecular Cancer Research. 14(2). 207–215. 19 indexed citations

Gannon, Hugh, Bruce A. Woda, & Stephen N. Jones. (2012). ATM Phosphorylation of Mdm2 Ser394 Regulates the Amplitude and Duration of the DNA Damage Response in Mice. Cancer Cell. 21(5). 668–679. 69 indexed citations

10.

Gannon, Hugh & Stephen N. Jones. (2012). Using Mouse Models to Explore MDM-p53 Signaling in Development, Cell Growth, and Tumorigenesis. Genes & Cancer. 3(3-4). 209–218. 19 indexed citations

11.

Gannon, Hugh, Lawrence A. Donehower, Stephen Lyle, & Stephen N. Jones. (2011). Mdm2–p53 signaling regulates epidermal stem cell senescence and premature aging phenotypes in mouse skin. Developmental Biology. 353(1). 1–9. 71 indexed citations

12.

Mason, Emily F., Yuxing Zhao, Pankuri Goraksha-Hicks, et al.. (2010). Aerobic Glycolysis Suppresses p53 Activity to Provide Selective Protection from Apoptosis upon Loss of Growth Signals or Inhibition of BCR-Abl. Cancer Research. 70(20). 8066–8076. 39 indexed citations

13.

Coles, Andrew H., Hugh Gannon, Anna Cerny, Evelyn A. Kurt‐Jones, & Stephen N. Jones. (2010). Inhibitor of growth-4 promotes IκB promoter activation to suppress NF-κB signaling and innate immunity. Proceedings of the National Academy of Sciences. 107(25). 11423–11428. 49 indexed citations

14.

Sluss, Hayla K., Hugh Gannon, Andrew H. Coles, et al.. (2010). Phosphorylation of p53 Serine 18 Upregulates Apoptosis to Suppress Myc-Induced Tumorigenesis. Molecular Cancer Research. 8(2). 216–222. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact